Literature DB >> 18332839

Frontal-subcortical dementias.

Raphael M Bonelli1, Jeffrey L Cummings.   

Abstract

Frontal-subcortical dementias are a heterogeneous group of disorders that share primary pathology in subcortical structure and a characteristic pattern of neuropsychologic impairment. Their clinical presentation is characterized by memory disorders, an impaired ability to manipulate acquired knowledge, important changes of personality (apathy, inertia, or depression), and slowed thought processes (or bradyphrenia). It also has marked frontal dysfunction. Classic frontal-subcortical dementias include Huntington chorea, Parkinson disease dementia, progressive supranuclear palsy, thalamic degeneration, subcortical vascular dementia, multiple sclerosis, the acquired immunodeficiency syndrome dementia complex, depressive pseudodementia, and some other rare dementias like spinocerebellar degenerative syndromes, Hallervorden-Spatz disease, choreoacanthocytosis, idiopathic basal ganglia calcification, Guamanian parkinsonism-dementia complex, corticobasal degeneration multiple system atrophy, Wilson disease, metachromatic leukodystrophy, adrenoleukodystrophy, hypoparathyroidism, sarcoidosis, and other CNS inflammatory disorders. Anatomic data suggest that the frontal signs result from a disconnection of the frontal cortex from the basal ganglia. However, most frontal-subcortical dementias show cortical atrophy in later stages, and cortical dementias have subcortical pathology at some point. In fact, the concept might be seen as a continuum, and only the 2 extremes would be represented by pure cortical or subcortical pathology. Anyway, subcortical disorders may still be more similar to one another than they are to AD. Possibly, frontal-subcortical and cortical dementias are the description of the prior main target of the disease process, ending up in both cases in a global dementia. Although the dichotomy cortical versus frontal-subcortical dementia is not strict, the 2 concepts still seem to have advantages.

Entities:  

Mesh:

Year:  2008        PMID: 18332839     DOI: 10.1097/NRL.0b013e31815b0de2

Source DB:  PubMed          Journal:  Neurologist        ISSN: 1074-7931            Impact factor:   1.398


  32 in total

1.  Intuition, insight, and the right hemisphere: Emergence of higher sociocognitive functions.

Authors:  Simon M McCrea
Journal:  Psychol Res Behav Manag       Date:  2010-03-03

2.  "Frontal" behaviors before the diagnosis of Huntington's disease and their relationship to markers of disease progression: evidence of early lack of awareness.

Authors:  Kevin Duff; Jane S Paulsen; Leigh J Beglinger; Douglas R Langbehn; Chiachi Wang; Julie C Stout; Christopher A Ross; Elizabeth Aylward; Noelle E Carlozzi; Sarah Queller
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2010       Impact factor: 2.198

3.  Cognitive impairment in progressive supranuclear palsy is associated with tau burden.

Authors:  Shunsuke Koga; Adam Parks; Koji Kasanuki; Monica Sanchez-Contreras; Matthew C Baker; Keith A Josephs; J Eric Ahlskog; Ryan J Uitti; Neill Graff-Radford; Jay A van Gerpen; Zbigniew K Wszolek; Rosa Rademakers; Dennis W Dickson
Journal:  Mov Disord       Date:  2017-10-30       Impact factor: 10.338

Review 4.  [Demyelinating disorders].

Authors:  T Weber; W Köhler
Journal:  Nervenarzt       Date:  2010-04       Impact factor: 1.214

5.  Profile of cognitive impairment and underlying pathology in multiple system atrophy.

Authors:  Shunsuke Koga; Adam Parks; Ryan J Uitti; Jay A van Gerpen; William P Cheshire; Zbigniew K Wszolek; Dennis W Dickson
Journal:  Mov Disord       Date:  2016-11-15       Impact factor: 10.338

6.  The cell cycle regulator phosphorylated retinoblastoma protein is associated with tau pathology in several tauopathies.

Authors:  Jeremy G Stone; Sandra L Siedlak; Massimo Tabaton; Asao Hirano; Rudy J Castellani; Corrado Santocanale; George Perry; Mark A Smith; Xiongwei Zhu; Hyoung-gon Lee
Journal:  J Neuropathol Exp Neurol       Date:  2011-07       Impact factor: 3.685

7.  The patient who falls: "It's always a trade-off".

Authors:  Mary E Tinetti; Chandrika Kumar
Journal:  JAMA       Date:  2010-01-20       Impact factor: 56.272

8.  The relationship between impairment of voluntary movements and cognitive impairment in Huntington's disease.

Authors:  Jirí Klempír; Olga Klempírová; Jan Stochl; Natasa Spacková; Jan Roth
Journal:  J Neurol       Date:  2009-05-16       Impact factor: 4.849

9.  Cognitive follow up of a small cohort of Huntington's disease patients over a 5 year period.

Authors:  Sarah L Mason; Ruwani Wijeyekoon; Rachel Swain; Aileen K Ho; Emma L Smith; Barbara Sahakian; Roger A Barker
Journal:  PLoS Curr       Date:  2010-09-02

10.  Cognition in patients with newly diagnosed brain metastasis: profiles and implications.

Authors:  Adam Gerstenecker; Louis B Nabors; Karen Meneses; John B Fiveash; Daniel C Marson; Gary Cutter; Roy C Martin; Christina A Meyers; Kristen L Triebel
Journal:  J Neurooncol       Date:  2014-07-18       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.